Online inquiry

IVTScrip™ mRNA-Human ACADVL, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK9410MR)

This product GTTS-WK9410MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the ACADVL protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_000018.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 37
UniProt ID P49748
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ACADVL, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) (GTTS-WK9410MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK14704MR IVTScrip™ mRNA-Human AGMO, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AGMO
GTTS-WK21400MR IVTScrip™ mRNA-Human ALDH3A2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ALDH3A2
GTTS-WK27188MR IVTScrip™ mRNA-Human ARV1, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ARV1
GTTS-WK14792MR IVTScrip™ mRNA-Human Aldehyde Dehydrogenase 1-A1, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA Aldehyde Dehydrogenase 1-A1
GTTS-WK0001MR IVTScrip™ mRNA-Human Intestinal Alkaline Phosphatase, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA Intestinal Alkaline Phosphatase
GTTS-WK10955MR IVTScrip™ mRNA-Human ACSS2, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ACSS2
GTTS-WK15687MR IVTScrip™ mRNA-Human ALAS1, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ALAS1
GTTS-WK19606MR IVTScrip™ mRNA-Human ALDH9A1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ALDH9A1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW